(Q37804476)

23 August 2017

Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy (English)

1 reference

23 August 2017

1 reference

R Speeckaert

1

1 reference

23 August 2017

N van Geel

2

1 reference

23 August 2017

K V Vermaelen

3

1 reference

23 August 2017

J Lambert

4

1 reference

23 August 2017

M Van Gele

5

1 reference

23 August 2017

M M Speeckaert

6

1 reference

23 August 2017

L Brochez

7

1 reference

23 August 2017

19 November 2010

1 reference

Pigment Cell & Melanoma Research

23 August 2017

1 reference

23 August 2017

24

1 reference

23 August 2017

334-344

1 reference

23 August 2017

2

1 reference

Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

23 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Management of nevi in transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

The immunopathology of regression in benign lichenoid keratosis, keratoacanthoma and halo nevus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Presence and localization of T-cell subsets in relation to melanocyte differentiation antigen expression and tumour regression as assessed by immunohistochemistry and molecular analysis of microdissected T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Histological regression in primary cutaneous melanoma: recognition, prevalence and significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Plasmacytoid dendritic cells in the skin: to sense or not to sense nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell-mediated anti-tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Targets of protective tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Ultrastructure of Halo Nevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Long-term follow-up of a patient with eruptive melanocytic nevi after Stevens-Johnson syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Cutaneous perspectives on adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Prognostic significance of autoimmunity during treatment of melanoma with interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Vitiligo and melanoma-associated hypopigmentation (MAH): shared and discriminative features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Mast cell and T cell communication; amplification and control of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Overcoming immunological tolerance to melanoma: Targeting CTLA-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

The evolving function of Langerhans cells in adaptive skin immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Dermoscopy patterns of halo nevi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Immune surveillance in the skin: mechanisms and clinical consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Toll-like receptors in the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Deepening our understanding of immune sentinels in the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Vitiligo in an urban academic setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Harnessing autoimmunity (vitiligo) to treat melanoma: a myth or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Lethal "thin" malignant melanoma. Identifying patients at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Immunocytochemical Analysis of the Cellular Infiltrate in Primary Regressing and Non-Regressing Malignant Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Immunosuppression and melanocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

Vaccine-specific local T cell reactivity in immunotherapy-associated vitiligo in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00799.X

10.1111/J.1755-148X.2010.00799.X

21 January 2018

Identifiers

DOI

1 reference

release_hguetyb4vrai7areuazoy4wo6i

23 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hguetyb4vrai7areuazoy4wo6i

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference